Lamivudine and hepatitis B reactivation.
Hsu
Chiun
C
Cheng
Ann-Lii
AL
Chen
Pei-Jer
PJ
D000970:Antineoplastic Agents / Q000009:adverse effects*; D000998:Antiviral Agents / Q000627:therapeutic use*; D003627:Data Interpretation, Statistical; D019694:Hepatitis B, Chronic / Q000517:prevention & control / Q000821:virology*; D006801:Humans; D016867:Immunocompromised Host; D019259:Lamivudine / Q000627:therapeutic use*; D014775:Virus Activation / Q000187:drug effects*
D000970:Antineoplastic Agents; D000998:Antiviral Agents; D019259:Lamivudine